BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7892201)

  • 1. The leukemic core binding factor beta-smooth muscle myosin heavy chain (CBF beta-SMMHC) chimeric protein requires both CBF beta and myosin heavy chain domains for transformation of NIH 3T3 cells.
    Hajra A; Liu PP; Wang Q; Kelley CA; Stacy T; Adelstein RS; Speck NA; Collins FS
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):1926-30. PubMed ID: 7892201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of core-binding factor alpha (CBF alpha) reverses cellular transformation by the CBF beta-smooth muscle myosin heavy chain chimeric oncoprotein.
    Hajra A; Liu PP; Speck NA; Collins FS
    Mol Cell Biol; 1995 Sep; 15(9):4980-9. PubMed ID: 7651416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core binding factor beta-smooth muscle myosin heavy chain chimeric protein involved in acute myeloid leukemia forms unusual nuclear rod-like structures in transformed NIH 3T3 cells.
    Wijmenga C; Gregory PE; Hajra A; Schröck E; Ried T; Eils R; Liu PP; Collins FS
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1630-5. PubMed ID: 8643682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates.
    Adya N; Stacy T; Speck NA; Liu PP
    Mol Cell Biol; 1998 Dec; 18(12):7432-43. PubMed ID: 9819429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia.
    Liu P; Tarlé SA; Hajra A; Claxton DF; Marlton P; Freedman M; Siciliano MJ; Collins FS
    Science; 1993 Aug; 261(5124):1041-4. PubMed ID: 8351518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimerization via its myosin domain facilitates nuclear localization and inhibition of core binding factor (CBF) activities by the CBFbeta-smooth muscle myosin heavy chain myeloid leukemia oncoprotein.
    Kummalue T; Lou J; Friedman AD
    Mol Cell Biol; 2002 Dec; 22(23):8278-91. PubMed ID: 12417730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chimeric protein, PEBP2 beta/CBF beta-SMMHC, disorganizes cytoplasmic stress fibers and inhibits transcriptional activation.
    Tanaka Y; Fujii M; Hayashi K; Chiba N; Akaishi T; Shineha R; Nishihira T; Satomi S; Ito Y; Watanabe T; Satake M
    Oncogene; 1998 Aug; 17(6):699-708. PubMed ID: 9715271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The core binding factor (CBF) alpha interaction domain and the smooth muscle myosin heavy chain (SMMHC) segment of CBFbeta-SMMHC are both required to slow cell proliferation.
    Cao W; Adya N; Britos-Bray M; Liu PP; Friedman AD
    J Biol Chem; 1998 Nov; 273(47):31534-40. PubMed ID: 9813068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukemic core binding factor beta-smooth muscle myosin heavy chain (CBF beta-SMMHC) chimeric protein requires both CBF beta and myosin heavy chain domains for transformation of NIH 3T3 cells.
    Adelstein RS; Collins FS; Hajra A; Kelley CA; Liu PP; Speck NA; Stacy T; Wang Q
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15523. PubMed ID: 9340650
    [No Abstract]   [Full Text] [Related]  

  • 10. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain.
    Durst KL; Lutterbach B; Kummalue T; Friedman AD; Hiebert SW
    Mol Cell Biol; 2003 Jan; 23(2):607-19. PubMed ID: 12509458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells.
    Cao W; Britos-Bray M; Claxton DF; Kelley CA; Speck NA; Liu PP; Friedman AD
    Oncogene; 1997 Sep; 15(11):1315-27. PubMed ID: 9315100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.
    Shurtleff SA; Meyers S; Hiebert SW; Raimondi SC; Head DR; Willman CL; Wolman S; Slovak ML; Carroll AJ; Behm F
    Blood; 1995 Jun; 85(12):3695-703. PubMed ID: 7780153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular insights into PEBP2/CBF beta-SMMHC associated acute leukemia revealed from the structure of PEBP2/CBF beta.
    Goger M; Gupta V; Kim WY; Shigesada K; Ito Y; Werner MH
    Nat Struct Biol; 1999 Jul; 6(7):620-3. PubMed ID: 10404215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation.
    Kanno Y; Kanno T; Sakakura C; Bae SC; Ito Y
    Mol Cell Biol; 1998 Jul; 18(7):4252-61. PubMed ID: 9632809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional domains of the t(8;21) fusion protein, AML-1/ETO.
    Lenny N; Meyers S; Hiebert SW
    Oncogene; 1995 Nov; 11(9):1761-9. PubMed ID: 7478604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
    Miller JD; Stacy T; Liu PP; Speck NA
    Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PEBP2beta/CBF beta-SMMHC chimeric protein is localized both in the cell membrane and nuclear subfractions of leukemic cells carrying chromosomal inversion 16.
    Kanto S; Chiba N; Tanaka Y; Fujita S; Endo M; Kamada N; Yoshikawa K; Fukuzaki A; Orikasa S; Watanabe T; Satake M
    Leukemia; 2000 Jul; 14(7):1253-9. PubMed ID: 10914550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis.
    Lukasik SM; Zhang L; Corpora T; Tomanicek S; Li Y; Kundu M; Hartman K; Liu PP; Laue TM; Biltonen RL; Speck NA; Bushweller JH
    Nat Struct Biol; 2002 Sep; 9(9):674-9. PubMed ID: 12172539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of G(1) cooperates with core binding factor beta-smooth muscle myosin heavy chain to induce acute leukemia in mice.
    Yang Y; Wang W; Cleaves R; Zahurak M; Cheng L; Civin CI; Friedman AD
    Cancer Res; 2002 Apr; 62(8):2232-5. PubMed ID: 11956074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia with Inv (16) produces a chimeric transcription factor with a myosin heavy chain tail.
    Liu P; Seidel N; Bodine D; Speck N; Tarlé S; Collins FS
    Cold Spring Harb Symp Quant Biol; 1994; 59():547-53. PubMed ID: 7587111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.